Skip to main content
Premium Trial:

Request an Annual Quote

Lester Crawford, Mark McClellan, Adrian Dillon, Ralph Boyd Jr., Richard Syron, Peter Ellison, Ralph Cicerone, Corey Goodman, William Haseltine

The Bush administration announced Monday that it will nominate Lester Crawford, acting commissioner of the Food and Drug Administration since March, to be commissioner of the agency, filling the opening created when Mark McClellan was appointed to head the Centers for Medicare and Medicaid Services of the Department of Health and Human Services.

Prior to becoming acting commissioner, Crawford, a veterinarian by training, served as a deputy FDA commissioner. Previously, he was chairman of the department of physiology-pharmacology at the University of Georgia

Adrian Dillon, chief financial officer for Agilent Technologies, has been named executive vice president for finance and administration, effective March 1. In addition to his current responsibilities for finance, planning and corporate development, information technology and workplace services, Dillon will be responsible for global sourcing, India operations, corporate relations, customer financing and contracts, the company said in a statement.

Ralph Boyd Jr. last week was named chairman of the Freddie Mac Foundation, a charitable organization. He replaces Richard Syron, chairman and CEO of Freddie Mac, who will remain on the board. Syron formerly was chairman of Thermo Electron before joining Freddie Mac.

Peter Ellison will resign as dean of the Graduate School of Arts and Sciences at Harvard University, effective at the end of the year. He will remain as professor of anthropology, the school said. Ellison was responsible for combining three Harvard biological science programs into the Harvard Integrated Life Sciences Program, according to a report in the Harvard Crimson newspaper.

Ralph Cicerone, chancellor of the University of California, Irvine, has been elected as the next president of the National Academy of Science, with his six-year term beginning July 1. Barbara Schaal, professor of biology at Washington University, St. Louis, was elected vice president. She will serve a four-year term. Named to the governing council were: Claude Canizares, professor of experimental physics and associate provost at Massachusetts Institute of Technology; Gerald Fischbach, executive vice president for health and biomedical sciences and dean of medicine at Columbia University's College of Physicians and Surgeons; Jerry Gollub, professor of natural sciences at Haverford College; and Joyce Marcus, professor of cultural evolution at the University of Michigan. They will serve three-year terms.

BayBio, a life-sciences industry association for Northern California, has named Corey Goodman of Renovis, Victoria Hale of the Institute for OneWorld Health, Steve James of KAI Pharmaceuticals, Joel Marcus of Alexandria Real Estate Equities, Phil Moody of Chiron, Alan Mendelson of Latham & Watkins, Kim Popovits of Genomic Health, and Dan Welch of InterMune to the board of directors.

William Haseltine, the founder of Human Genome Sciences and a professor at the Scripps Research Institute, last week was named chairman of the scientific advisory board of Matrix Laboratories of Hyderabad, India.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.